Skip to main content
. 2020 Apr 17;9(4):295. doi: 10.3390/pathogens9040295

Figure 5.

Figure 5

Ribavirin (RBV) abolished HEV replication in PHESCs. PHESCs, challenged with stool-derived HEV-1 (A) or stool-derived HEV-3 (B), were treated (grey) or not (black) with RBV (50 µM final conc). (C) Huh 7.5 infected with HEV-3 virus and treated (grey) or not (black) with RBV (50 µM final conc). The supernatants were collected from treated and untreated cells at 14- and 21-days post-infection, and HEV RNA was quantified in these samples by qRT-PCR. Depicted are the mean values of three independent experiments ± SEM.